| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | SVP, CSO, GLOBAL RESEARCH | Common Stock, $0.01 par value | 107K | $19.2M | $178.99 | Feb 28, 2024 | Direct |
| AbbVie Inc. | SVP, CSO, GLOBAL RESEARCH | Option (Right to Buy) | 18.9K | $2.73M | $144.54 | Feb 15, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ABBV | AbbVie Inc. | Feb 28, 2024 | 1 | -$3.69M | 4 | Mar 1, 2024 | SVP, CSO, GLOBAL RESEARCH |
| ABBV | AbbVie Inc. | Feb 15, 2024 | 5 | $0 | 4 | Feb 20, 2024 | SVP, CSO, GLOBAL RESEARCH |
| ABBV | AbbVie Inc. | Feb 28, 2023 | 1 | -$4.31M | 4 | Mar 2, 2023 | SVP, R&D AND CSO |
| ABBV | AbbVie Inc. | Feb 16, 2023 | 5 | $0 | 4 | Feb 21, 2023 | SVP, R&D AND CSO |
| ABBV | AbbVie Inc. | Feb 25, 2022 | 1 | -$2.01M | 4 | Mar 1, 2022 | SVP, R&D and CSO |
| ABBV | AbbVie Inc. | Feb 17, 2022 | 5 | $0 | 4 | Feb 22, 2022 | SVP, R&D and CSO |